(Q24243005)

title

Interventions for preventing oral candidiasis for patients with cancer receiving treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

1 reference

1 reference

2

H V Worthington

H V

Worthington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

1

J E Clarkson

J E

Clarkson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

O B Eden

3

O B

Eden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

Cochrane Database of Systematic Reviews

12 May 2020

language of work or name

1 reference

24 January 2007

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

page(s)

CD003807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Prophylaxis of oropharyngeal candidiasis with clotrimazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Cyclophosphamide metabolism is affected by azole antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Empirical antibacterial therapy in febrile, granulocytopenic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Prophylactic use of fluconazole in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Interventions for treating oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Interventions for preventing oral candidiasis for patients with cancer receiving treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

21 January 2018

1 reference

12 December 2020

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

12 December 2020

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

12 December 2020

Antifungal prophylaxis with low doses fluconazole in patients with hematological malignancies

1 reference

12 December 2020

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.

1 reference

12 December 2020

A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy

1 reference

12 December 2020

Itraconazole (Orungal) in the treatment of mycotic infections in oncologic patients

1 reference

12 December 2020

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

12 December 2020

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias

1 reference

12 December 2020

Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B

1 reference

12 December 2020

Oral candidiasis prevention in transplantation patients: a comparative study

1 reference

12 December 2020

Interventions for treating oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

Interventions for preventing oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study

1 reference

12 December 2020

Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study

1 reference

12 December 2020

[Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents]

1 reference

12 December 2020

Management of fungal infection in neutropenic patients with fluconazole

1 reference

12 December 2020

Prophylaxis of oropharyngeal candidiasis with fluconazole.

1 reference

12 December 2020

Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic Disease

1 reference

12 December 2020

Prophylaxis of candidiasis in cancer patients

1 reference

12 December 2020

Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy

1 reference

12 December 2020

Prophylaxis of fungal infections with itraconazole during remission-induction therapy

1 reference

12 December 2020

Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group

1 reference

12 December 2020

Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse

1 reference

12 December 2020

Comparison of clotrimazole with nystatin in preventing oral candidiasis in neutropaenic patients

1 reference

12 December 2020

Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study

1 reference

12 December 2020

Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study

1 reference

12 December 2020

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

12 December 2020

Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study

1 reference

12 December 2020

A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients

1 reference

12 December 2020

Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome.

1 reference

12 December 2020

Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses

1 reference

12 December 2020

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

12 December 2020

Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment

1 reference

12 December 2020

Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients

1 reference

12 December 2020

Prophylaxis of Oral Candidiasis With Clotrimazole Troches

1 reference

12 December 2020

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

12 December 2020

Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes

1 reference

12 December 2020

Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study

1 reference

12 December 2020

A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group

1 reference

12 December 2020

Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection

1 reference

12 December 2020

Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies.

1 reference

12 December 2020

Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies

1 reference

12 December 2020

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

1 reference

12 December 2020

Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

1 reference

12 December 2020

Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

1 reference

12 December 2020

Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B

1 reference

12 December 2020

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

12 December 2020

[Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?]

1 reference

12 December 2020

Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.

1 reference

12 December 2020

Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants

1 reference

12 December 2020

[Prevention of mucositis]

1 reference

12 December 2020

[Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors]

1 reference

12 December 2020

A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia

1 reference

12 December 2020

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003807.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD003807.PUB3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

release_od6e6cwzjvhbldhh3i47uv7ine

12 May 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6746214&resulttype=core&format=json

12 May 2020

PubMed publication ID

17253497

1 reference